Unique ID issued by UMIN | UMIN000004661 |
---|---|
Receipt number | R000005511 |
Scientific Title | NOBORI Biolimus-Eluting versus XIENCE/PROMUS Everolimus-eluting Stent Trial |
Date of disclosure of the study information | 2010/12/03 |
Last modified on | 2021/04/27 11:06:38 |
NOBORI Biolimus-Eluting versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NEXT
NOBORI Biolimus-Eluting versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NEXT
Japan |
Coronary artery disease
Cardiology |
Others
NO
To evaluate the efficacy and safety of Biolimus-eluting stent.
Safety,Efficacy
Taget lesion revascularization within one year after percutaneous coronary intervention.
Incidence of cardiac death and myocardial infarction within 3 years after percutaneous coronary intervention.
Interventional
Parallel
Randomized
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Percutaneous coronary intervention using biolimus-eluting stent.
Percutaneous coronary intervention using everolimus-eluting stent.
Not applicable |
Not applicable |
Male and Female
Patients undergoing percutaneous coronary intervention using drug eluting stent.
none
3200
1st name | |
Middle name | |
Last name | Takeshi Kimura |
Kyoto University
Cardiovascular Medicine
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
1st name | |
Middle name | |
Last name |
Kyoto University
Cardiovascular Medicine
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
Kyoto University
Terumo corporation
Profit organization
NO
2010 | Year | 12 | Month | 03 | Day |
Unpublished
Completed
2010 | Year | 12 | Month | 03 | Day |
2011 | Year | 02 | Month | 10 | Day |
2011 | Year | 05 | Month | 01 | Day |
2017 | Year | 03 | Month | 01 | Day |
2010 | Year | 12 | Month | 02 | Day |
2021 | Year | 04 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005511
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |